TAP Holdings

TAP Biosystems, formerly known as The Automation Partnership, was a leading UK-based biotechnology company specializing in the design and development of automated cell culture and fermentation systems. The company's flagship technology, the ambr automated micro bioreactor system, revolutionized bioprocess development by enabling high-throughput screening and optimization of cell lines and media at a micro-scale. By automating complex manual processes, TAP Biosystems significantly improved the efficiency, scalability, and reproducibility of biological production for the pharmaceutical and regenerative medicine industries. In 2013, the company was acquired by Sartorius Stedim Biotech, where its advanced automation platforms continue to serve as industry standards for biopharmaceutical research and manufacturing.